The North America Mobile ECG Devices Market would witness market growth of 11.5% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 2,216.4 thousand units, showcasing a growth of 16.8% (2019-2022).
The market is expanding significantly due to growing technological advancements. The FDA recently approved a single-lead ECG smartwatch, indicating significant progress in this field and proving the device's ability to identify atrial fibrillation (AF) in the general population. The possibility for smartwatches to develop into effective instruments for ongoing AF monitoring is highlighted by this development. In addition to smartwatches, the market is now being served by a number of cutting-edge gadgets for AF monitoring and detection.
Another significant technological development is the miniaturization of ECG hardware. Because they are lighter and more portable than previous models, modern mobile ECG devices can be used in a variety of environments. Additionally, the incorporation of machine learning algorithms and artificial intelligence (AI) has enabled these devices to offer predictive analytics and intelligent insights, helping medical professionals diagnose and treat cardiac conditions more successfully.
Urbanization and changing lifestyles in Mexico have led to increased rates of sedentary behavior, unhealthy dietary habits, and higher stress levels. These factors contribute to developing risk factors for CVDs, such as obesity, hypertension, and diabetes. Mexico faces a growing obesity pandemic closely linked to an increased risk of CVDs. Obesity is associated with hypertension, diabetes, and dyslipidemia, contributing to heart disease.
Canada has an aging population, and older adults are more likely to develop cardiovascular conditions. As per the Canadian Institute for Health Information, the number of Canadians 65 and older is projected to increase by 68% during the next 20 years. Its size has increased by more than threefold in the last 40 years. In 2017, the population was approximately 6.2 million. It is anticipated to reach a population of 10.4 million in 2037. This population in Canada is projected to increase by 2.1 times by 2037 from its size in 2017. Due to the above factors, North America's market will increase significantly in the coming years.
The US market dominated the North America Mobile ECG Devices Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,585.3 Million by 2030. The Canada market is exhibiting a CAGR of 14.1% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 13.1% during (2023 - 2030).
Based on Modality, the market is segmented into Handheld, Band, Pen, and Others. Based on End-use, the market is segmented into Hospitals & Diagnostic Centers, Ambulatory Care, and Homecare. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include New York Plastic Surgical Group, PC (Long Island Plastic Surgical Group), Nihon Kohden Corporation, GE HealthCare Technologies, Inc., Medtronic PLC, iRhythm Technologies, Inc., Koninklijke Philips N.V., OMRON Corporation, Nureca Limited (Dr Trust), EMAY, and AliveCor, Inc.
The market is expanding significantly due to growing technological advancements. The FDA recently approved a single-lead ECG smartwatch, indicating significant progress in this field and proving the device's ability to identify atrial fibrillation (AF) in the general population. The possibility for smartwatches to develop into effective instruments for ongoing AF monitoring is highlighted by this development. In addition to smartwatches, the market is now being served by a number of cutting-edge gadgets for AF monitoring and detection.
Another significant technological development is the miniaturization of ECG hardware. Because they are lighter and more portable than previous models, modern mobile ECG devices can be used in a variety of environments. Additionally, the incorporation of machine learning algorithms and artificial intelligence (AI) has enabled these devices to offer predictive analytics and intelligent insights, helping medical professionals diagnose and treat cardiac conditions more successfully.
Urbanization and changing lifestyles in Mexico have led to increased rates of sedentary behavior, unhealthy dietary habits, and higher stress levels. These factors contribute to developing risk factors for CVDs, such as obesity, hypertension, and diabetes. Mexico faces a growing obesity pandemic closely linked to an increased risk of CVDs. Obesity is associated with hypertension, diabetes, and dyslipidemia, contributing to heart disease.
Canada has an aging population, and older adults are more likely to develop cardiovascular conditions. As per the Canadian Institute for Health Information, the number of Canadians 65 and older is projected to increase by 68% during the next 20 years. Its size has increased by more than threefold in the last 40 years. In 2017, the population was approximately 6.2 million. It is anticipated to reach a population of 10.4 million in 2037. This population in Canada is projected to increase by 2.1 times by 2037 from its size in 2017. Due to the above factors, North America's market will increase significantly in the coming years.
The US market dominated the North America Mobile ECG Devices Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,585.3 Million by 2030. The Canada market is exhibiting a CAGR of 14.1% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 13.1% during (2023 - 2030).
Based on Modality, the market is segmented into Handheld, Band, Pen, and Others. Based on End-use, the market is segmented into Hospitals & Diagnostic Centers, Ambulatory Care, and Homecare. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include New York Plastic Surgical Group, PC (Long Island Plastic Surgical Group), Nihon Kohden Corporation, GE HealthCare Technologies, Inc., Medtronic PLC, iRhythm Technologies, Inc., Koninklijke Philips N.V., OMRON Corporation, Nureca Limited (Dr Trust), EMAY, and AliveCor, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Modality (Volume, Thousand Units, USD Billion, 2019-2030)- Handheld
- Band
- Pen
- Others
- Hospitals & Diagnostic Centers
- Ambulatory Care
- Homecare
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- New York Plastic Surgical Group, PC (Long Island Plastic Surgical Group)
- Nihon Kohden Corporation
- GE HealthCare Technologies, Inc.
- Medtronic PLC
- iRhythm Technologies, Inc.
- Koninklijke Philips N.V.
- OMRON Corporation
- Nureca Limited (Dr Trust)
- EMAY
- AliveCor, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. North America Mobile ECG Devices Market, by Modality
Chapter 6. North America Mobile ECG Devices Market, by End-use
Chapter 7. North America Mobile ECG Devices Market, by Country
Chapter 8. Company Profiles
Companies Mentioned
- New York Plastic Surgical Group, PC (Long Island Plastic Surgical Group)
- Nihon Kohden Corporation
- GE HealthCare Technologies, Inc.
- Medtronic PLC
- iRhythm Technologies, Inc.
- Koninklijke Philips N.V.
- OMRON Corporation
- Nureca Limited (Dr Trust)
- EMAY
- AliveCor, Inc.
Methodology
LOADING...
